Invention Grant
- Patent Title: Human anti-IP-10 antibodies uses thereof
- Patent Title (中): 人抗IP-10抗体使用
-
Application No.: US12529124Application Date: 2008-02-28
-
Publication No.: US08258267B2Publication Date: 2012-09-04
- Inventor: Nicolas Fischer , Marie Kosco-Vilbois , Olivier Leger
- Applicant: Nicolas Fischer , Marie Kosco-Vilbois , Olivier Leger
- Applicant Address: CH Geneva
- Assignee: NovImmune S.A.
- Current Assignee: NovImmune S.A.
- Current Assignee Address: CH Geneva
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Agent Ivor R. Elrifi
- International Application: PCT/US2008/002650 WO 20080228
- International Announcement: WO2008/106200 WO 20080904
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K39/40 ; C07K17/00
Abstract:
The invention relates to fully human antibodies, and fragments thereof, that bind to interferon-inducible-protein-10 (IP-IO, CXCL1O), thereby modulating the interaction between IP-IO and its receptor, CXCR3, and/or modulating the biological activities of IP-IO. The invention also relates to the use of such anti-IP-10 antibodies in the prevention or treatment of immune-related disorders and in the amelioration of one or more symptoms associated with an immune-related disorder.
Public/Granted literature
- US20100322941A1 Human Anti-IP-10 Antibodies Uses Thereof Public/Granted day:2010-12-23
Information query
